Northwestern Medicine Connect

Thursday, December 7, 2023, 7:00 AM - Friday, December 8, 2023, 4:00 PM, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia


This live course serves all levels of physicians and will address this gap through didactic lectures and live endoscopy to feature the most advanced interventional endoscopy interventions presented as live-endoscopy session streamed from Saudi Arabia and Northwestern coupled with panel discussions with international experts.

1. Review novel innovation in screening and surveillance for Barrett’s Esophagus and esophageal cancer.
2. Employ best practices in colonoscopy quality, polypectomy and endoscopic mucosal resection.
3. Describe the current state-of-the-art management of pancreaticobiliary disease.
4. Demonstrate endoscopic techniques for advanced tissue resection and pancreaticobiliary disease.
5. Discuss the endoscopic management of obesity and metabolic disorders.
6. Identify novel innovation and techniques in third space endoscopy.
7. Explain the current role of artificial intelligence in gastroenterology practice.

The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

The Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 13.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AMA PRA Category 1 Credits™ (13.50 hours), Non-Physician Attendance (13.50 hours)

Mitigation of Relevant Financial Relationships

Feinberg School of Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to control the content of a Continuing Education activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.